Omnicell (OMCL) Non-Current Assets (2010 - 2026)
Omnicell's (OMCL) quarterly Non-Current Assets came in at $1.3 billion in Q2 2026, down 2.86% year-over-year from $1.3 billion in Q2 2025, and down 1.43% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Omnicell (OMCL) Non-Current Assets (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Non-Current Assets for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 2.86% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 1.56% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 0.83% from the prior year.
- Non-Current Assets was $1.3 billion for Q2 2026 at Omnicell, down from $1.3 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.3 billion in Q1 2022 and troughed at $1.3 billion in Q2 2026.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 37.57% in 2022 and slipped 2.86% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $1.3 billion in 2022, then fell by 2.23% to $1.3 billion in 2023, then gained by 0.47% to $1.3 billion in 2024, then fell by 0.83% to $1.3 billion in 2025, then slipped by 2.41% to $1.3 billion in 2026.
- The last three Non-Current Assets figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 4.64 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 1.26 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.29 Bn |
| Jun 30, 2025 | 1.30 Bn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 1.31 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.33 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.35 Bn |
| Dec 31, 2021 | 1.36 Bn |
| Sep 30, 2021 | 1.16 Bn |